Generic drugs refer to alternative drugs
that have the same active ingredients, dosage form, route of administration and therapeutic effect as the original drug.
Compared with the original drug, the price of generic drugs is cheaper, which is of great significance
to reduce the burden of public medication and save medical costs.
In order to further improve the quality of generic drugs and benefit the people, the national drug safety "Twelfth Five-Year Plan" and "Thirteenth Five-Year Plan" and other plans and documents have put forward the task
of carrying out the consistency evaluation of generic drugs.
So far, major domestic pharmaceutical companies have also started a large-scale generic drug consistency evaluation process
.
At present, many companies have performed very well in the evaluation of generic drugs
.
For example, recently, Liaoning Fangda Group Northeast Pharmaceutical announced that it had received the "Drug Supplement Application Approval Notice" for the company's Piracetam tablets approved and issued by the National Medical Products Administration, marking that the product successfully passed the consistency evaluation
of the quality and efficacy of generic drugs.
It is worth mentioning that this is the 8th evaluated product
of Northeast Pharmaceutical this year.
It is understood that in recent years, the research and development speed of Northeast Pharmaceutical has advanced by leaps and bounds, and this year alone, 8 product specifications have passed the consistency evaluation of generic drugs, mainly involving anti-infection system drugs, antiviral drugs, cardiovascular and cerebrovascular drugs, digestive system drugs and other fields
.
Among them, on November 9, Northeast Pharmaceutical announced that the company recently received the approval notice of drug supplement application for piracetam tablets approved and issued by the National Medical Products Administration
.
The drug is suitable for acute and chronic cerebrovascular diseases, brain trauma, various toxic encephalopathy and other reasons caused by memory loss and mild and moderate brain dysfunction, and can also be used for the treatment
of children's intellectual retardation.
On October 31, Northeast Pharmaceutical announced that it recently received the "Drug Supplement Application Approval Notice"
on tinidazole tablets approved and issued by the National Medical Products Administration.
The drug is indicated for the treatment of the following diseases: trichomoniasis, giardiasis, amebiasis, bacterial vaginosis, combined with antibiotics and antacids for the eradication of duodenal ulcer and anaerobic infection associated with Helicobacter pylori; It can also be used to prevent postoperative infections caused by anaerobic bacteria, such as colon, gastrointestinal, and genitourinary infections
.
In September, Northeast Pharmaceutical issued an announcement that the application for registration of "acetyl-L-carnitine hydrochloride" API passed the CDE approval; On August 26, Northeast Pharmaceutical Amantadine Hydrochloride Tablets has also received the "Drug Supplement Application Approval Notice" approved and issued by the State Food and Drug Administration.
.
.
Through the consistency evaluation of generic drugs, it is of great significance
to enhance the brand value of products, enhance the discourse power of product markets, and optimize the product structure of enterprises.
Since Northeast Pharmaceutical joined Liaoning Fangda Group in 2018, it has actually been accelerating the pace of consistency evaluation of
generic drugs.
It is reported that earlier Northeast Pharmaceutical said that it would actively fulfill its corporate social responsibility, greatly improve the quality of generic drugs, and make generic drugs consistent with the quality and efficacy of the original drugs
.
The industry expects that in the future, Northeast Pharmaceutical will make generic drugs consistent with the quality and efficacy of original drugs by continuously increasing R&D investment and improving innovation capabilities, and produce more, better quality and more affordable domestic generic drugs, benefiting the majority of patients and making new and greater contributions to China's pharmaceutical and
health cause.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
